Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Oct 1;53(4):187-194.
doi: 10.1249/JES.0000000000000370. Epub 2025 Sep 22.

Exercise to Mitigate Premature Vascular Aging After Doxorubicin Breast Cancer Therapy

Affiliations
Review

Exercise to Mitigate Premature Vascular Aging After Doxorubicin Breast Cancer Therapy

Zachary S Clayton et al. Exerc Sport Sci Rev. .

Abstract

Breast cancer treatment induces a state of premature vascular aging. This article examines the hypothesis that high-intensity interval training may be a time-efficient form of exercise training that effectively mitigates premature vascular aging in breast cancer survivors.

Keywords: adjuvant breast cancer therapy; breast cancer; chemotherapy; exercise; oxidative stress; vascular aging.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None.

Figures

Figure 1.
Figure 1.
Working hypothesis of breast cancer chemotherapy-induced premature vascular aging: mitigation by high-intensity interval training. Proposed model illustrating the potential protective effects of high-intensity interval training (HIIT) as an exercise preconditioning strategy against chemotherapy-induced premature vascular aging. Chemotherapy contributes to vascular dysfunction through endothelial dysfunction, arterial stiffening, reduced nitric oxide (NO) bioavailability, increased reactive oxygen species (ROS) bioactivity and inflammation, elastin fragmentation, and collagen deposition. These mechanisms collectively accelerate vascular aging and elevate cardiovascular risk. Implementing a time-efficient form of exercise training, such as HIIT, between breast cancer diagnosis and the onset of chemotherapy treatment (~3 wk) may help mitigate these effects, potentially improving vascular resilience and reducing cardiovascular complications in patients with breast cancer.
Figure 2.
Figure 2.
Premature vascular aging induced by administration of doxorubicin (Doxo) chemotherapy. Doxo administration in young adult mice induces premature vascular aging as evidenced by (A) reduced carotid artery endothelium-dependent dilation to increasing doses of acetylcholine (ACh) and (B) elevated aortic pulse wave velocity. *P < 0.05 vs Young Control. [Panel A adapted from Clayton et al. (53). Copyright © 2020 The Authors. CC BY-NC-ND. Used with permission.] [Panel B adapted from Clayton et al. (54). Copyright © 2021 American Heart Association. Used with permission.]
Figure 3.
Figure 3.
Conceptual model depicting key factors influencing premature vascular aging in breast cancer. Central to the figure is the relation between breast cancer and vascular aging, with contributing factors including the type of exercise training, chronological age, menopausal status, breast cancer type, which informs the type of treatment, and social factors. Different breast cancer subtypes, such as invasive ductal carcinoma, inflammatory breast cancer, and invasive lobular carcinoma, may have distinct impacts on vascular health. Social determinants of health, including socioeconomic status, healthcare access, social network, and psychosocial stress, can further influence outcomes. In contrast, resistance training may serve as a protective factor by improving vascular function and mitigating premature aging effects.

References

    1. Timmis A, Townsend N, Gale CP, et al. ; European Society of Cardiology. European Society of Cardiology: cardiovascular disease statistics 2019. Eur. Heart J 2020;41(1) 12–85. - PubMed
    1. Jaul E, Barron J. Age-related diseases and clinical and public health implications for the 85 years old and over population. Front. Public Health 2017;5:335. - PMC - PubMed
    1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107(1) 139–46. - PubMed
    1. Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin. Sci. (Lond) 2011;120(9) 357–75. - PMC - PubMed
    1. Donato AJ, Morgan RG, Walker AE, Lesniewski LA. Cellular and molecular biology of aging endothelial cells. J. Mol. Cell. Cardiol 2015;89(Pt B):122–35. - PMC - PubMed

MeSH terms

LinkOut - more resources